Acadian Asset Management
SQZ

Acadian Asset Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Acadian Asset Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-46,249
Closed -$668K – 2103
2021
Q2 		$668K Buy
+46,249
New +$604K ﹤0.01% 1051

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management's SQZ Position: Q3 2021 in Review

Acadian Asset Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2021, closing a stake of 46,249 shares — an estimated $668K sold.

Acadian Asset Management first reported a position in SQZ in Q2 2021 and held it in 1 quarter. The position peaked at $668K in Q2 2021. 44 funds tracked by Wall St. Rank hold SQZ as of Q3 2021.

  • Acadian Asset Management reported no remaining SQZ Biotechnologies Company position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 46,249 SQZ Biotechnologies Company shares in Q3 2021, an estimated $668K.
  • Acadian Asset Management first reported a position in SQZ Biotechnologies Company in Q2 2021 and held it in 1 quarter.
  • Acadian Asset Management's SQZ Biotechnologies Company position peaked at $668K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.